X-152728200-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001102576.3(CSAG1):c.41T>C(p.Leu14Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 8/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 23)
Consequence
CSAG1
NM_001102576.3 missense
NM_001102576.3 missense
Scores
2
7
Clinical Significance
Conservation
PhyloP100: -0.727
Genes affected
CSAG1 (HGNC:24294): (chondrosarcoma associated gene 1) This gene encodes a member of a family of tumor antigens. The protein is expressed in chondrosarcomas, but may also be expressed in normal tissues such as testis. Alternative splicing of this gene results in two transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.32186192).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSAG1 | NM_001102576.3 | c.41T>C | p.Leu14Pro | missense_variant | 3/4 | ENST00000452779.3 | NP_001096046.2 | |
CSAG1 | NM_153478.3 | c.41T>C | p.Leu14Pro | missense_variant | 4/5 | NP_705611.2 | ||
CSAG1 | XM_047441858.1 | c.41T>C | p.Leu14Pro | missense_variant | 3/4 | XP_047297814.1 | ||
CSAG1 | XM_047441859.1 | c.41T>C | p.Leu14Pro | missense_variant | 3/4 | XP_047297815.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSAG1 | ENST00000452779.3 | c.41T>C | p.Leu14Pro | missense_variant | 3/4 | 1 | NM_001102576.3 | ENSP00000396520 | A2 | |
CSAG1 | ENST00000370287.7 | c.41T>C | p.Leu14Pro | missense_variant | 4/5 | 1 | ENSP00000359310 | A2 | ||
CSAG1 | ENST00000370291.6 | c.41T>C | p.Leu14Pro | missense_variant | 4/4 | 1 | ENSP00000359314 | P4 | ||
CSAG1 | ENST00000361211.9 | c.48T>C | p.Pro16= | synonymous_variant, NMD_transcript_variant | 3/4 | 1 | ENSP00000354898 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2022 | The c.41T>C (p.L14P) alteration is located in exon 4 (coding exon 2) of the CSAG1 gene. This alteration results from a T to C substitution at nucleotide position 41, causing the leucine (L) at amino acid position 14 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;T
LIST_S2
Benign
T;.;T
MetaRNN
Benign
T;T;T
PROVEAN
Benign
N;N;N
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;D;D
Vest4
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.